Filing Details
- Accession Number:
- 0001209191-20-055604
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-22 18:15:47
- Reporting Period:
- 2020-10-21
- Accepted Time:
- 2020-10-22 18:15:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1706431 | Vir Biotechnology Inc. | VIR | Biological Products, (No Disgnostic Substances) (2836) | 812730369 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1787370 | Phillip Pang | C/O Vir Biotechnology, Inc. 499 Illinois Street, Suite 500 San Francisco CA 94158 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-10-21 | 7,870 | $1.53 | 37,647 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-10-21 | 2,315 | $1.58 | 39,962 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-10-21 | 2,315 | $5.18 | 42,277 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-10-21 | 7,500 | $35.42 | 34,777 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-10-21 | 5,000 | $35.59 | 29,777 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2020-10-21 | 7,870 | $0.00 | 7,870 | $1.53 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2020-10-21 | 2,315 | $0.00 | 2,315 | $1.58 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2020-10-21 | 2,315 | $0.00 | 2,315 | $5.18 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 92,591 | 2028-04-27 | No | 4 | M | Direct | |
| 48,612 | 2028-07-19 | No | 4 | M | Direct | |
| 67,129 | 2029-03-11 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020.
- 1/4 of the shares subject to the stock option vested and became exercisable on April 27, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.
- 1/4 of the shares subject to the stock option vested and became exercisable on July 19, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.
- 1/4 of the shares subject to the stock option vested and became exercisable on March 11, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
